Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter LR Jr.

Arch Gen Psychiatry. 2002 Mar;59(3):250-61.

PMID:
11879163
2.

Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders.

Jiménez F, Nicolini H, Lozano AM, Piedimonte F, Salín R, Velasco F.

World Neurosurg. 2013 Sep-Oct;80(3-4):S30.e17-25. doi: 10.1016/j.wneu.2012.07.010. Epub 2012 Jul 21. Review.

PMID:
22824558
3.

Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetine.

Ninan PT.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:89-96. Review.

PMID:
14566204
4.

Predictors of response to serotonin reuptake inhibitors in obsessive-compulsive disorder.

Hazari N, Narayanaswamy JC, Arumugham SS.

Expert Rev Neurother. 2016 Oct;16(10):1175-91. doi: 10.1080/14737175.2016.1199960. Epub 2016 Jun 30. Review.

PMID:
27282021
5.

Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies.

Su L, Cai Y, Xu Y, Dutt A, Shi S, Bramon E.

BMC Psychiatry. 2014 Nov 19;14:321. doi: 10.1186/s12888-014-0321-9. Review.

6.

[Use of positron emission tomography in psychiatry].

Degrell I, Berecz R, Glaub T, Lengyel Z, Egerházi A, Szakáll S Jr, Trón L.

Orv Hetil. 2002 May 26;143(21 Suppl 3):1311-4. Review. Hungarian.

PMID:
12077925

Supplemental Content

Support Center